Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival-Reference-Cited by-同舟云学术

Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival

Published:2016-02-23 Issue:14 Volume:7 Page:18573-18584
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Corvigno Sara¹,Wisman G. Bea A.²,Mezheyeuski Artur¹,van der Zee Ate G.J.²,Nijman Hans W.²,Åvall-Lundqvist Elisabeth¹³,Östman Arne¹,Dahlstrand Hanna¹⁴

Affiliation:

1. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

2. Department of Gynecologic Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

3. Department of Oncology and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

4. Unit for Breast, Gynecologic Cancer and Sarcoma, Department of Oncology, Karolinska University Hospital, Stockholm, Sweden

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional and clinical roles of stromal PDGF receptors in tumor biology;Cancer and Metastasis Reviews;2024-07-09

2. Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment;Frontiers in Drug Delivery;2024-02-01

3. A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activation;mAbs;2023-06-18

4. Vessel size as a marker of survival in estrogen receptor positive breast cancer;Breast Cancer Research and Treatment;2023-05-24

5. Vessel size as a marker of survival in estrogen receptor positive breast cancer;2022-11-17